David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 10,000 shares at $2.49 ($25K) on 2011-11-25, disclosed to the SEC on 2011-11-28.
Open-market purchase of $25k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.46 | 2,000 | $5K | 19.8% |
| 2 | $2.49 | 4,000 | $10K | 40.0% |
| 3 | $2.50 | 4,000 | $10K | 40.2% |
| Total | $2.49 avg | 10,000 | $25K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |